Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$48.3K Sell
15,390
-1,167
-7% -$4.65K 0.12% 171
2025
Q3
$63.7K Buy
+16,557
New +$82.9K 0.03% 483
2024
Q4
Sell
-37,783
Closed -$207K 728
2024
Q3
$207K Buy
+37,783
New +$283K 0.05% 745

Other funds holding AGEN

Sherbrooke Park Advisers's AGEN Position: Q4 2025 in Review

Sherbrooke Park Advisers reduced its Agenus (AGEN) stake by 7% in Q4 2025, selling an estimated $4.65K and leaving 15,390 shares worth $48.3K. The position accounts for 0.12% of the portfolio, ranked #171.

Sherbrooke Park Advisers first reported a position in AGEN in Q3 2024 and has held it in 3 quarters since. The position peaked at $207K in Q3 2024. 96 funds tracked by Wall St. Rank hold AGEN as of Q4 2025.

  • Sherbrooke Park Advisers held 15,390 shares of Agenus worth $48.3K as of Q4 2025.
  • Sherbrooke Park Advisers sold 1,167 Agenus shares in Q4 2025, an estimated $4.65K.
  • Agenus made up 0.12% of Sherbrooke Park Advisers's portfolio in Q4 2025, its #171 holding.
  • Sherbrooke Park Advisers first reported a position in Agenus in Q3 2024 and has held it in 3 quarters since.
  • Sherbrooke Park Advisers's Agenus position peaked at $207K in Q3 2024.
  • 96 funds tracked by Wall St. Rank held Agenus as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.